Home › Medicine › Sun Pharmaceutical Industries INC

Sun Pharmaceutical Industries INC

Low risk

The FDA considers this unlikely to cause harm. Return it for a refund if you would rather not keep it.

Class III

  • Unlikely to cause any adverse health consequence, but the product breaks FDA rules.
  • Refunds don't require a receipt, and you don't need proof of purchase.
  • FDA status: Ongoing.

What was recalled

Source: FDA · synced 29 Jul 2026 13:14
Low risk Filed 2026-07-08

Failed Impurities/Degradation Specifications

Fexofenadine Hydrochloride Tablets, USP 180 mg, Antihistamine, 150 Tablets per bottle, Distributed by: Ohm Laboratories, Inc., New Brunswick, NJ 08901. NDC 66336-561-30

Check these codes: Lot, expiry: Lot DNG0283A, exp 03/31/2027; Lots DNF0922A and DNF0923B, exp 10/31/2026

9,048 bottles · distributed u.s. nationwide Recall D-0654-2026 on FDA.gov ↗
Ad slot · height reserved before load

Watch Sun Pharmaceutical Industries INC for new recalls

One email per recall. Nothing else, ever.